Genmab A/S GE9
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Genmab A/S is a biotechnology company headquartered in Copenhagen, Denmark, specializing in the discovery and development of antibody-based therapeutics primarily for cancer and other serious diseases. Founded in 1998, it focuses on innovative human antibody technologies to create differentiated products that address u…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryDenmark
Employees2,639
TickerGE9
Statistics
Market Cap$15.74B
Revenue (TTM)$4.70B
Net Income—
Net Margin—
EPS—
P/E18.72
P/S3.35
P/B2.66
EV/EBITDA12.83
ROE15.0%
Dividend Yield—
Price$256.46
Data: Twelve Data · Revenue = mcap / P/S